Ozempic Weight-Loss Drug Linked to Blindness in New Study
Drugmaker Novo Nordisk says its product is safe, while company stock took a hit.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
Why this matters
This cryptocurrency story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on DecryptRelated market context
Visa Says Business Payments Now Drive 17% Of Stablecoin-Linked Card Volume
TL;DR Visa says roughly 17% of its stablecoin-linked card volume in fiscal 2026 year-to-date came from business and commercial car...
OpenWorld Begins Nasdaq Trading As VerifyMe Deal Creates Public Tokenization Company
TL;DR OpenWorld and VerifyMe have completed their business combination, with the combined company trading on Nasdaq under OPNW fro...
Bitcoin survived 5% yields but crypto’s cheap-money era did not
The US 10-year Treasury yield touched 5.34% on Oct. 1, its highest since 2002, capping a third quarter in which it climbed almost...
US targets $17 billion Russia-linked crypto payment network using USDT as an escape route
The US sanctioned the Russia-linked A7 Network and proposed new restrictions to cut its crypto intermediaries off from global mark...
Aave v3 exploit drains up to $310K after Safe module attack
The exploit highlights the critical need for rigorous security audits of third-party modules in DeFi, as vulnerabilities can lead...
San Francisco Fed study finds stablecoin Treasury growth offsets China’s retreat
A San Francisco Fed study finds stablecoin issuers added about $200 billion in Treasuries, offsetting over 40% of China's decline...